Does adjuvant androgen suppression after radiotherapy for prostate cancer improve long-term outcomes?

被引：3
作者：
Bolla, M [1 ]
机构：
[1] Univ Grenoble, Dept Radiotherapy, Ctr Hosp, F-38043 Grenoble, France
来源：
NATURE CLINICAL PRACTICE UROLOGY | 2005年 / 2卷 / 11期
关键词：
androgen suppression; goserelin; prostate cancer; radiotherapy; RTOG;
D O I：
10.1038/ncpuro0331
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：536 / 537
页数：2
相关论文
共 5 条
[1]   Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial [J].
Bolla, M ;
Collette, L ;
Blank, L ;
Warde, P ;
Dubois, JB ;
Mirimanoff, RO ;
Storme, G ;
Bernier, J ;
Kuten, A ;
Sternberg, C ;
Mattelaer, J ;
Torecilla, JL ;
Pfeffer, JR ;
Cutajar, CL ;
Zurlo, A ;
Pierart, M .
LANCET, 2002, 360 (9327) :103-108
[2]   Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: The Radiation Therapy Oncology Group Protocol 92-02 [J].
Hanks, GE ;
Pajak, TF ;
Porter, A ;
Grignon, D ;
Brereton, H ;
Venkatesan, V ;
Horwitz, EM ;
Lawton, C ;
Rosenthal, SA ;
Sandler, HM ;
Shipley, WU .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (21) :3972-3978
[3]   Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate [J].
Lawton, CA ;
Winter, K ;
Murray, K ;
Machtay, M ;
Mesic, JB ;
Hanks, GE ;
Coughlin, CT ;
Pilepich, MV .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 49 (04) :937-946
[4]   Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: Report of Radiation Therapy Oncology Group Protocol 85-31 [J].
Pilepich, MV ;
Caplan, R ;
Byhardt, RW ;
Lawton, CA ;
Gallagher, MJ ;
Mesic, JB ;
Hanks, GE ;
Coughlin, CT ;
Porter, A ;
Shipley, WU ;
Grignon, D .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) :1013-1021
[5]   Phase III Radiation Therapy Oncology Group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate [J].
Pilepich, MV ;
Winter, K ;
John, MJ ;
Mesic, JB ;
Sause, W ;
Rubin, P ;
Lawton, C ;
Machtay, M ;
Grignon, D .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 50 (05) :1243-1252
1